These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 4924709)

  • 1. [1st experiences with the use of a new liver protector in liver diseases].
    Gómez Ponsa JM
    Rev Esp Enferm Apar Dig; 1970 Nov; 32(5):593-600. PubMed ID: 4924709
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of chronic liver diseases with thioctic acid].
    Möller E; Brinkmann W; Weber O; Wildhirt E
    Med Klin; 1967 Mar; 62(10):380-4. PubMed ID: 4874626
    [No Abstract]   [Full Text] [Related]  

  • 3. [Therapeutic progress in chronic liver diseases].
    Wildhirt E
    Dtsch Z Verdau Stoffwechselkr; 1968; 28(2):207-8. PubMed ID: 4894834
    [No Abstract]   [Full Text] [Related]  

  • 4. [Use of lipoic acid and its amide in chronic liver diseases].
    Romanov VS
    Sov Med; 1971; 34(12):43-5. PubMed ID: 4948129
    [No Abstract]   [Full Text] [Related]  

  • 5. [Therapy of chronic liver diseases with prednisolone and alpha-lipoic acid].
    Loginow AS
    Dtsch Z Verdau Stoffwechselkr; 1970; 30(1):19-23. PubMed ID: 4925665
    [No Abstract]   [Full Text] [Related]  

  • 6. [Observations on the treatment of chronic inflammatory liver diseases with the preparation Hepasteril B comp].
    Busse K; Otremba P
    Soins; 1970; 15(7):2608-13. PubMed ID: 4918343
    [No Abstract]   [Full Text] [Related]  

  • 7. [Lipoic acid therapy in chronic active hepatitis].
    László B; Méhesfalvy E
    Orv Hetil; 1980 Dec; 121(52):3195-8. PubMed ID: 6784064
    [No Abstract]   [Full Text] [Related]  

  • 8. [Experiences with the use of vitamin B15 in the treatment of certain diseases of the liver].
    Anisimov VE
    Sov Med; 1966 Jun; 29(6):107-10. PubMed ID: 5988439
    [No Abstract]   [Full Text] [Related]  

  • 9. [A contribution to the treatment of chronic liver diseases (author's transl)].
    Möller E; Schmitt R
    Med Klin; 1976 Oct; 71(43):1831-5. PubMed ID: 825708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Further clinical experiences with ornithine aspartate in liver diseases].
    Wotzka R; Weber D
    Ther Ggw; 1972 Mar; 111(3):400-12. PubMed ID: 5024593
    [No Abstract]   [Full Text] [Related]  

  • 11. [Experiences with 6-mercaptopurine therapy in active chronic hepatopathies].
    Schimmelpfennig W; Schneider G; Theuer D; Wagner K; Zimmermann HB
    Dtsch Z Verdau Stoffwechselkr; 1969; 22():89-95. PubMed ID: 5380092
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical experiences with P-Carboxyphenylglycylaminoacetonitrile in refractory].
    Ota Y; Endo H
    Saishin Igaku; 1969 Jan; 24(1):185-7. PubMed ID: 5777190
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of chronic hepatitis and liver cirrhosis with 6-mercaptopurine and a methylhydrazine derivative].
    Göggel KH; Epperlein H
    Med Klin; 1965 Aug; 60(34):1362-8. PubMed ID: 5843139
    [No Abstract]   [Full Text] [Related]  

  • 14. [Prednisolone therapy of patients with chronic hepatitis and cirrhosis of the liver].
    Vasil'eva LN
    Klin Med (Mosk); 1966 May; 44(5):42-8. PubMed ID: 5990929
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical study on the effects of coenzyme A in liver diseases].
    Kanematsu Y; Okawa S; Himoto A; Inoue Y; Onishi K
    Naika Hokan; 1968 Mar; 15(3):67-75. PubMed ID: 5691520
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinico-experimental findings on the use of a new liver protective agent].
    Catalfamo G; Melotti G; Soffritti E
    Minerva Med; 1967 Apr; 58(34 Suppl):1605-12. PubMed ID: 4226047
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effectiveness of the use of immunosuppressive agents in the treatment of chronic hepatitis and liver cirrhosis].
    Vakulenko EF
    Vrach Delo; 1975 Sep; (9):55-6. PubMed ID: 1210301
    [No Abstract]   [Full Text] [Related]  

  • 18. [Therapeutic use of ornithine-carbamyl-transferase in liver diseases].
    Maccá F; Gatta A; Caregaro L; Lauro S; Milani L; Zuin R; Menozzi L
    Minerva Dietol Gastroenterol; 1982; 28(1):71-8. PubMed ID: 7078779
    [No Abstract]   [Full Text] [Related]  

  • 19. [Blood coagulation activity in patients with chronic hepatitis and cirrhosis of the liver, treated with glucocorticoid hormones].
    Zlatkina AR; Levantovskaia OM; Kravtsova EF
    Ter Arkh; 1972 Apr; 44(4):98-102. PubMed ID: 5051568
    [No Abstract]   [Full Text] [Related]  

  • 20. [Therapy of acute and chronic liver diseases with combinations of vitamin B12 and anabolic hormones].
    Boeder KJ; Schmidt H; Khamsi A
    Med Welt; 1966 Apr; 14():730-4. PubMed ID: 5957304
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.